In-process testing and limits.
Sjöholm
I
I
Department of Pharmacy, Medical Products Agency, Uppsala, Sweden.
D000818:Animals; D001702:Biopharmaceutics / Q000592:standards; D001709:Biotechnology / Q000379:methods / Q000458:organization & administration / Q000592:standards*; D004247:DNA / Q000302:isolation & purification; D004269:DNA, Bacterial / Q000302:isolation & purification; D004340:Drug Contamination; D004341:Drug Evaluation; D004345:Drug Industry / Q000379:methods / Q000458:organization & administration / Q000592:standards*; D005060:Europe; D017408:Guidelines as Topic; D007218:Industrial Microbiology; D008322:Mammals / Q000235:genetics; D011786:Quality Control; D011994:Recombinant Proteins / Q000302:isolation & purification / Q000494:pharmacology / Q000592:standards; D013548:Sweden; D017749:Total Quality Management
D004269:DNA, Bacterial; D011994:Recombinant Proteins; D004247:DNA